Synaptive receives FDA clearance for point-of-care MRI

2020 02 20 00 48 1332 Approved Stamp 400

3D visualization firm Synaptive Medical has garnered U.S. Food and Drug Administration (FDA) clearance for its Evry dedicated head MRI system.

Designed for point-of-care imaging in critical care settings, Evry features a 0.5-tesla superconducting magnet, predefined imaging protocols, automated series planning, a detachable stretcher to support beside transfers, and a multichannel head coil, according to the vendor. It also doesn't require yearly cryogen refills, a cryogen pipe, reinforced flooring, or rigging or cranes to be used for delivery, Synaptive said.

The Toronto-based firm previously received Health Canada approval for Evry in February.

Page 1 of 610
Next Page